EcoDrugPlus

Protein Kinase C Alpha

Ensembl ID : ENSSVLG00005012642
Gene Symbol: PRKCA
1 Cross references
289 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSSVLG00005025955
Gene Symbol: PRKCB
1 Cross references
284 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSSVLG00005017697
Gene Symbol: PRKCD
1 Cross references
280 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSSVLG00005023394
Gene Symbol: PRKCE
1 Cross references
315 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSSVLG00005001876
Gene Symbol: PRKCH
1 Cross references
237 Possible Orthologues:

Protein Kinase C Gamma

Ensembl ID : ENSSVLG00005022850
Gene Symbol: PRKCG
1 Cross references
198 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSSVLG00005008431
Gene Symbol: PRKCQ
1 Cross references
203 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSSVLG00005000049
Gene Symbol: PRKCZ
1 Cross references
201 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSSVLG00005003998
Gene Symbol: PRKD1
1 Cross references
204 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSSVLG00005017657
Gene Symbol: PRKD3
1 Cross references
270 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Alpha

Ensembl ID : ENSSVLG00005025328
Gene Symbol: PRKACA
1 Cross references
283 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Beta

Ensembl ID : ENSSVLG00005023190
Gene Symbol: PRKACB
1 Cross references
297 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).